GGrantIndex
← Leaderboards

James N Jarvis

State University Of New York At Buffalo

$7,731,944
Attributed
$7,731,944
Total exposure
11
Grants
7
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $756.5K · FY200525
$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$7,731,944 · 11

By mechanism

R01$6,143,731 · 3
R21$1,424,252 · 4
R03$159,500 · 1
M01$4,461 · 3

Top collaborators

No co-investigators on record.

Most similar at State University Of New York At Buffalo

Same institution · by research overlap

Others in their field

Top investigators on “Genes

Research focus

GenesGene ExpressionChildChildhoodLaboratoriesChronic Childhood ArthritisResearch PersonnelBaseChronic DiseaseBiologicalAffectComplexGenome-WideSamplingInflammationChronicBiologyGenomeEnhancersCellsFutureResponseMolecularGenomics

Grant awards (29)

Epigenetic Mechanisms That Drive Genetic Risk in Juvenile Arthritis$602,438
R01 · FY2025 · AR · contact PI
Epigenetic Mechanisms That Drive Genetic Risk in Juvenile Arthritis$675,894
R01 · FY2024 · AR · contact PI
Epigenetic Mechanisms That Drive Genetic Risk in Juvenile Arthritis$631,104
R01 · FY2023 · AR · contact PI
3D Chromatin Studies in Pediatric B Cells To Study the Genetics of Autoimmunity$79,750
R03 · FY2023 · AI · contact PI
Epigenetic Mechanisms That Drive Genetic Risk in Juvenile Arthritis$653,112
R01 · FY2022 · AR · contact PI
3D Chromatin Studies in Pediatric B Cells To Study the Genetics of Autoimmunity$79,750
R03 · FY2022 · AI · contact PI
Using Chromatin Architecture to Develop of Therapeutic Pipeline for Juvenile Arthritis$170,186
R21 · FY2021 · AR · contact PI
Using Chromatin Architecture to Develop of Therapeutic Pipeline for Juvenile Arthritis$210,540
R21 · FY2020 · AR · contact PI
Identifying Causal Variants in Juvenile Arthritis Using a Massively Parallel Reporter Assay$175,450
R21 · FY2019 · AR · contact PI
Identifying Causal Variants in Juvenile Arthritis Using a Massively Parallel Reporter Assay$210,540
R21 · FY2018 · AR · contact PI
Microarray-Based Biomarkers in Juvenile Idiopathic Arthritis$485,545
R01 · FY2015 · AR · contact PI
Trophoblasts and Inflammation: An Epigenetic Approach$194,287
R21 · FY2015 · HD · contact PI
Microarray-Based Biomarkers in Juvenile Idiopathic Arthritis$518,020
R01 · FY2014 · AR · contact PI
Trophoblasts and Inflammation: An Epigenetic Approach$238,500
R21 · FY2014 · HD · contact PI
Microarray-Based Biomarkers in Juvenile Idiopathic Arthritis$474,424
R01 · FY2013 · AR · contact PI
Microarray-Based Biomarkers in Juvenile Idiopathic Arthritis$28,397
R01 · FY2013 · AR · contact PI
Microarray-Based Biomarkers in Juvenile Idiopathic Arthritis$467,614
R01 · FY2012 · AR · contact PI
Microarray-Based Biomarkers in Juvenile Idiopathic Arthritis$460,339
R01 · FY2011 · AR · contact PI
Microarray-Based Biomarkers in Juvenile Idiopathic Arthritis$136,254
R01 · FY2011 · AR · contact PI
Dynamics of Therapeutic Response Within the TREAT Trial$683,705
R01 · FY2010 · AI · contact PI
Dynamics of Therapeutic Response Within the TREAT Trial$9,861
R01 · FY2010 · AI · contact PI
Dynamics of Therapeutic Response Within the TREAT Trial$317,024
R01 · FY2009 · AI · contact PI
RESEARCH IN NEONATAL IMMUNITY$2,062
M01 · FY2005 · RR
IDENTIFYING NOVEL IMMUNE REGULATORS IN PLACENTAL TROPHOBLASTS$1,718
M01 · FY2005 · RR
MICROARRAYS IN TREATED JUVENILE RHEUMATOID ARTHRITIS$681
M01 · FY2005 · RR
Leukocyte Microarrays in Juvenile Rheumatoid Arthritis$71,669
R21 · FY2003 · AR
Leukocyte Microarrays in Juvenile Rheumatoid Arthritis$39,915
R21 · FY2003 · AR
Leukocyte Microarrays in Juvenile Rheumatoid Arthritis$39,915
R21 · FY2003 · AR
Leukocyte Microarrays in Juvenile Rheumatoid Arthritis$73,250
R21 · FY2002 · AR